Cvs Health (CVS) Net Income towards Common Stockholders (2009 - 2026)

Cvs Health (CVS) has 18 years of Net Income towards Common Stockholders data on file, last reported at $3.0 billion in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 65.94% year-over-year to $3.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 billion (down 44.64% YoY) and the FY2025 annual result came in at $1.7 billion, down 62.32% from the prior year.
• Net Income towards Common Stockholders advanced to $3.0 billion in Q1 2026, from $2.9 billion in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $3.0 billion in Q2 2022 to a low of -$4.0 billion in Q3 2025.
• A 5-year average of $1.3 billion and a median of $1.9 billion in 2023 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders surged 166.64% — and 2025, when it plunged 5719.72%.
• Tracing CVS's Net Income towards Common Stockholders over 5 years: stood at $2.3 billion in 2022, then dropped by 12.22% to $2.0 billion in 2023, then fell by 20.71% to $1.6 billion in 2024, then jumped by 80.1% to $2.9 billion in 2025, then gained by 1.16% to $3.0 billion in 2026.
• The last three Net Income towards Common Stockholders figures came in at $3.0 billion (Q1 2026), $2.9 billion (Q4 2025), and -$4.0 billion (Q3 2025), per Business Quant data.